Variable | Score | Description | |||
---|---|---|---|---|---|
CHA2DS2VASc score | |||||
C | 1 | Congestive heart failure or LVEF ≤ 40% | |||
H | 1 | Hypertension; BP consistently > 140/90 mmHg, or controlled on medications | |||
A2 | 2 | Age ≥ 75 years | |||
D | 1 | Diabetes mellitus, defined as HbA1c ≥ 6.5 gm/dL or controlled on medications | |||
S2 | 2 | Stroke, TIA or systemic thromboembolism | |||
V | 1 | Vascular disease, defined as prior MI, peripheral arterial disease or aortic plaque | |||
A | 1 | Age 65–74 years | |||
Sc | 1 | Sex category (female)* | |||
Mehran’s risk score | |||||
Hypotension | 5 | Systolic BP < 80 mmHg or > 1 h on inotropic support | |||
Heart failure | 5 | NYHA class III/IV or recent pulmonary edema | |||
IABP | 5 | Intra-aortic balloon pump therapy | |||
Age | 4 | If > 75 years | |||
Anemia | 3 | HCT < 0.39 for males, < 0.36 for females | |||
Diabetes | 3 | Diabetes mellitus affecting blood sugar levels | |||
eGFR | 2 | For eGFR 60–40 mL/min | |||
 | 4 | For eGFR 40–20 mL/min | |||
 | 6 | For eGFR < 20 mL/min | |||
Contrast volume | Â | 1 point for every 100Â mL | |||
 | Total Mehran’s score | < 5 | 6–10 | 11–16 | > 16 |
 | CIN risk | 7.5% | 14% | 26.1% | 57.3% |
 | Dialysis risk | 0.04% | 0.12% | 1.09% | 12.6% |